Teligent Company Profile (NASDAQ:TLGT)

Analyst Ratings

Consensus Ratings for Teligent (NASDAQ:TLGT) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.50 (19.95% upside)

Analysts' Ratings History for Teligent (NASDAQ:TLGT)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016JMP SecuritiesInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Raymond James Financial Inc.Initiated CoverageStrong-Buy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Oppenheimer Holdings Inc.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016Deutsche Bank AGLower Price TargetHold$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Roth CapitalBoost Price TargetNeutral -> Buy$7.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Teligent (NASDAQ:TLGT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/22/2016        
7/28/2016Q2($0.02)$0.02$16.03 million$17.14 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116($0.03)$0.02$14.33 million$15.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.02)($0.02)$11.69 million$13.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Teligent (NASDAQ:TLGT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.01)($0.01)($0.01)
Q4 20161$0.02$0.02$0.02
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Teligent (NASDAQ:TLGT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Teligent (NASDAQ:TLGT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/11/2016James C GaleDirectorBuy15,000$4.91$73,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Jason Grenfell-GardnerCEOBuy10,500$4.82$50,610.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Teligent (NASDAQ:TLGT)
DateHeadline
07/28/16 07:11 PMStock is down at $7.92 (TLGT) Teligent, Inc. Announces Second Quarter... - Finance Daily
07/28/16 06:53 PMTeligent reports 2Q loss -
07/21/16 05:26 PMZimmer Biomet (ZBH) Q2 Earnings: A Beat in the Cards? -
07/20/16 07:51 PMEquity Roundup: Stock Performance Focus on Teligent Inc (NASDAQ:TLGT) - Press Telegraph
07/20/16 09:43 AMTeligent : Advances $50 Million Facility Expansion
07/19/16 07:01 PMOption Market: Teligent Inc Risk Hits An Elevated Level - CML News
07/19/16 07:01 PMStock in Positive Territory for the Quarter: Teligent, Inc. (NASDAQ:TLGT) - Engelwood Daily
07/19/16 07:00 PMEarnings Focus and Crowd Sourced Sentiment Review for Teligent Inc (NASDAQ:TLGT) - TGP
07/19/16 12:14 PMETF’s with exposure to Teligent, Inc. : July 19, 2016 -
07/15/16 12:06 PMTeligent, Inc. To Hold Conference Call For 2nd Quarter 2016 Results - Yahoo Finance
07/15/16 12:06 PMAnalyst Target and Average Rating Watch: Teligent Inc (NASDAQ:TLGT) - Press Telegraph
07/13/16 07:13 AMTeligent, Inc. To Hold Conference Call For 2nd Quarter 2016 Results - [at noodls] - BUENA, N.J., July 13, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ETon ...
07/12/16 11:09 AMTeligent Inc (NASDAQ:TLGT) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/09/16 09:47 AMTeligent (TLGT) ANDAs for Triamcinolone Topical Treatment Approved by FDA
07/09/16 09:47 AMTeligent, Inc. Receives Two FDA Approvals For Topical Prescription Portfolio - KAIT Jonesboro, AR - Region 8 News, weather, sports
07/08/16 09:39 AMTeligent, Inc. Receives Two FDA Approvals For Topical Prescription Portfolio - Yahoo Finance
07/08/16 07:11 AMTeligent, Inc. Receives Two FDA Approvals For Topical Prescription Portfolio - [at noodls] - BUENA, N.J., July 8, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that it has received approvals of the Company's abbreviated ...
07/07/16 09:34 AMTeligent, Inc. Advances $50 Million Facility Expansion - PR Newswire (press release)
07/07/16 09:34 AMCompany Stock Focus for Teligent Inc (NASDAQ:TLGT): Which Way Will Shares Head? - Press Telegraph
07/06/16 07:21 AMTeligent, Inc. Advances $50 Million Facility Expansion - [at noodls] - BUENA, N.J., July 6, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, recently held the formal groundbreaking ceremony for the ongoing expansion ...
07/02/16 09:23 AMCovering the Bases on Teligent Inc (NASDAQ:TLGT): Where is the Stock Going? - Press Telegraph
06/30/16 03:09 PMETF’s with exposure to Teligent, Inc. : June 30, 2016 -
06/28/16 08:58 AMTeligent : stock price target held steady to $0 as covered today by Raymond James
06/23/16 07:34 PMBiggest Movers in Manufacturing Stocks Now - CVV GNCA TANH MLSS - Investorplace.com
06/23/16 07:34 PMTeligent Inc (NASDAQ:TLGT) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 04:51 AMCoverage initiated on Teligent by Raymond James -
06/21/16 07:39 AMTeligent, Inc. To Present At JMP Securities Life Sciences Conference On June 21, 2016 - [at noodls] - BUENA, N.J., June 21, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jerseybased specialty generic pharmaceutical company, will be presenting at the JMP Securities Life Sciences Conference. ...
06/17/16 09:28 AMAllergan Glaucoma Gel Stent Filing Accepted for FDA Review
06/09/16 09:54 AMTeligent, Inc. (NASDAQ:TLGT) Fundamental Star Rating Report - CML News
05/27/16 03:06 PMTELIGENT, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu -
05/24/16 01:58 PMBull Vs. Bear: Teligent, Inc. -
05/19/16 07:02 PMETF’s with exposure to Teligent, Inc. : May 20, 2016 -
05/17/16 10:53 AMTeligent, Inc. :TLGT-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 10:31 AMTeligent: FDA Approves Triamcinolone Acetonide Ointment, Launch Planned For Q2 - (RTTNews.com) - Teligent, Inc. ( TLGT), a specialty generic pharmaceutical company, announced Monday that it has received approval of its abbreviated new drug application or ANDA from the U.S. Food and Drug Administration or FDA of Triamcinolone Acetonide ...
05/16/16 07:32 AMTeligent, Inc. Announces FDA Approval Of Triamcinolone Acetonide Ointment USP, 0.1% - [at noodls] - BUENA, N.J., May 16, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that it has received approval of the Company's abbreviated ...
05/16/16 07:08 AM8:08 am Teligent confirms approval of ANDA from FDA of Triamcinolone Acetonide Ointment USP, 0.1% -
05/12/16 10:17 AMPerformance Recap and Target Perspective on Teligent Inc (NASDAQ:TLGT) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Teligent Inc (NASDAQ:TLGT)B.O.D.Y ConfidentialIn the latest trading session, shares of Teligent Inc (NASDAQ:TLGT) moved -1.46%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/10/16 05:16 PMTELIGENT, INC. Files SEC form 10-Q, Quarterly Report -
05/10/16 07:28 AMTeligent, Inc. To Present At Bank of America Merrill Lynch Annual Health Care Conference On May 10, 2016 - [at noodls] - BUENA, N.J., May 10, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jerseybased specialty generic pharmaceutical company, will be presenting at the Bank of America Merrill Lynch 2016 Health ...
05/06/16 10:36 AMAverage Analyst Rating for Teligent Inc (NASDAQ:TLGT) - B.O.D.Y Confidential - Average Analyst Rating for Teligent Inc (NASDAQ:TLGT)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2 on Teligent Inc (NASDAQ:TLGT) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/03/16 10:02 AMSmall Cap Gainers: Teligent (NASDAQ:TLGT), Newpark Resources Inc. (NYSE:NR), TimkenSteel (NYSE:TMST), The ... - KC Register - Small Cap Gainers: Teligent (NASDAQ:TLGT), Newpark Resources Inc. (NYSE:NR), TimkenSteel (NYSE:TMST), The ...KC RegisterTeligent, Inc. (NASDAQ:TLGT) announced its financial results for the first quarter ended March 31, 2016. Revenue from the Teligent portfolio of injectable and topical products was $9.2 million for the quarter, a 13.5% increase over the same quarter ...and more »
05/03/16 07:45 AMTeligent (TLGT) Worth a Look: Stock Up 6.3% in Session -
05/03/16 07:10 AMTeligent, Inc. To Present At Deutsche Bank 41st Annual Health Care Conference On May 4, 2016 - [at noodls] - BUENA, N.J., May 3, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jerseybased specialty generic pharmaceutical company, will be presenting at the Deutsche Bank 41 Annual Health Care Conference. ...
05/02/16 10:51 AMActive Stocks Rising, May 2 – ENVA, EHTH, TLGT, PCMI, CIR, SCSS, MNST, PNK, SKYW, BGS - Teligent Inc (New) (TLGT) traded at $6.03 + 0.96 (18.93 percent). The company is +19.70 percent during the last four weeks, -32.25 percent year to date, and +8.65 percent in the past four quarters. PCM Inc. (PCMI) traded at $9.45 + 1.20 (14.55 percent).
04/28/16 05:13 PMTeligent reports 1Q loss -
04/28/16 03:26 PMTeligent, Inc. Announces First Quarter 2016 Results - [at noodls] - BUENA, N.J., April 28, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended ...
04/28/16 10:12 AMShare Performance and Target Price Review Teligent Inc (NASDAQ:TLGT) - B.O.D.Y Confidential - Share Performance and Target Price Review Teligent Inc (NASDAQ:TLGT)B.O.D.Y ConfidentialDuring the most recent trading session, shares of Teligent Inc (NASDAQ:TLGT) ended up with a move of -3.35%. Sell-side analysts have given a consensus target price of $9.00 on company shares. Target price projections may differ greatly from one analyst ...and more »
04/28/16 10:11 AMTeligent Inc (NASDAQ:TLGT) Share Rating Recap - B.O.D.Y Confidential - Teligent Inc (NASDAQ:TLGT) Share Rating RecapB.O.D.Y ConfidentialShares of Teligent Inc (NASDAQ:TLGT) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/27/16 10:31 AMTeligent, Inc. (NASDAQ:TLGT) To Report Earnings Tomorrow - Share Trading News - Teligent, Inc. (NASDAQ:TLGT) To Report Earnings TomorrowShare Trading NewsThey expect $-0.03 EPS, down 100% or $0.03 from last year's $0 per share. At the moment 5 analysts are watching Teligent, Inc. (NASDAQ:TLGT), 0 rate it “Buy”, 2 “Outperform”, 3 “Underperform”, 0 “Sell”, while 0 “Hold”. Looking forward, for the quarter ...
04/26/16 10:33 AMTeligent Inc (NASDAQ:TLGT) Wall Street Rating in Focus - News Tribune - Teligent Inc (NASDAQ:TLGT) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 3 equity research firms that cover shares of Teligent Inc (NASDAQ:TLGT). Sell ...and more »

Social

About Teligent

Teligent logoTeligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It has two platforms: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. Its pipeline includes over 30 Abbreviated New Drug Applications filed with the United States Food and Drug Administration for additional pharmaceutical products. It holds additional over 40 product candidates at various stages of its development pipeline, 10 of which are on stability testing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TLGT
  • CUSIP:
Key Metrics:
  • Previous Close: $7.92
  • 50 Day Moving Average: $7.37
  • 200 Day Moving Average: $6.22
  • P/E Ratio: N/A
  • P/E Growth: 54.93
  • Market Cap: $420.23M
  • Beta: 0.95
  • Current Year EPS Consensus Estimate: $-0.02 EPS
  • Next Year EPS Consensus Estimate: $0.16 EPS
Additional Links:
Teligent (NASDAQ:TLGT) Chart for Friday, July, 29, 2016